Beam Therapeutics Inc.

Q2 2023 13F Holders

Symbol: BEAM
CUSIP: 07373V105
Type: Equity
Class: COM
Num filings: 210
Total reported value, excl. options: $2.05 B

Compare 2023 Q2 to

Manager	Report Date	Value ($000)	Shares	Option Type